References
- Hu, G., Qiao, Q., Tuomilehto, J., Balkau, B., Borch-Johnsen, K., and Pyorala, K. (2004). Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164, 1066-1076. https://doi.org/10.1001/archinte.164.10.1066
- Azizi, F., Salehi, P., Etemadi, A., and Zahedi-Asl, S. (2003). Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61, 29-37. https://doi.org/10.1016/S0168-8227(03)00066-4
- Onat, A., Ceyhan, K., Basar, O., Erer, B., Toprak, S., and Sansoy, V. (2002). Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165, 285-292. https://doi.org/10.1016/S0021-9150(02)00236-8
- Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V.P., and Kothari, K. (2003). Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 61, 69-76. https://doi.org/10.1016/S0168-8227(03)00085-8
- Wisse, B.E. (2004). The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 2792-2800. https://doi.org/10.1097/01.ASN.0000141966.69934.21
- Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., Takishita, S. (2004): Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876. https://doi.org/10.1111/j.1523-1755.2004.00582.x
- Ejerblad, E., Fored, M., Lindblad, P., Fryzek, J., McLaughlin, J.K., and Nyren, O. (2006). Obesity and risk of chronic renal failure. J Am Soc Nephrol 17, 1695-1702. https://doi.org/10.1681/ASN.2005060638
- Filler, G., Boken Kamp, A., Hotmann, W., Le Bricon, T., Martnez-Bru, C., and Grubb, A. (2005). Cystatin C as marker of GFR, history indication and future research. Clin Biochem 38, 1-8. https://doi.org/10.1016/j.clinbiochem.2004.09.025
- Henskens, Y.M.C., Veerman, E.C.I., and Nieuw Amerongen, A.V. (1996). Cystatins in health and disease. Biol Chem Hoppe-Seyler 377, 71-86.
- Sarnak, M.J., Katz, R., Stehman-Breen, C.O., Fried, L.F., Nancy Swords Jenny, Bruce, M.P., Newman, A., Siscovick, D., Shlipak, M; The Cardiovascular Health Study. (2005). Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults. Ann Intern Med 142, 497-505. https://doi.org/10.7326/0003-4819-142-7-200504050-00008
- O'Hare, A., Newman, A., Katz, R., Fried, L., Stehman-Breen, C., Seliger, S., Siscovick, D., Shlipak, M.S., and Cystatin, C. (2005). Incident peripheral arterial disease events in the elderly. Arch Intern Med 165, 2666- 2670. https://doi.org/10.1001/archinte.165.22.2666
- Hoehner, C.M., Greenlund, K.J., Rith-Najarian, S., Casper, M.L., and McClellan, W.M. (2002). Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter- Tribal Heart Project. J Am Soc Nephrol 13, 1626-1634. https://doi.org/10.1097/01.ASN.0000015762.92814.85
- Hsu, C.Y., McCulloch, C.E., Iribarren, C., Darbinian, J., and Go, A.S. (2006). Body mass index and risk for end-stage renal disease. Ann Intern Med 144, 21-28. https://doi.org/10.7326/0003-4819-144-1-200601030-00006
- Agnani, S., Vachharajani, V.T, Gupta, R., Atray, N.K., and Vachharajani, T.J. (2005). Does treating obesity stabilize chronic kidney disease? BMC Nephrol 6, 7. https://doi.org/10.1186/1471-2369-6-7
- Chagnac, A., Weinstein, T., Herman, M., Hirsh, J., Gafter, U., and Ori, Y. (2003). The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14, 1480-1486. https://doi.org/10.1097/01.ASN.0000068462.38661.89
- Kambham, N., Markowitz, G.S., Valeri, A.M., Lin, J., and D'Agati, V.D. (2001). Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59, 1498-1509. https://doi.org/10.1046/j.1523-1755.2001.0590041498.x
- Armstrong, K.A, Campbell, S.B, Hawley, C.M., Nicol, D.L, Johson, D.W., and Isbel, N.M. (2005). Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 5, 2710-2718. https://doi.org/10.1111/j.1600-6143.2005.01073.x
- Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993). Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259, 87-91. https://doi.org/10.1126/science.7678183
- Wisse. B.E. (2004). The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 2792-2800 https://doi.org/10.1097/01.ASN.0000141966.69934.21
- Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., and Garg, R. (2005). Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454. https://doi.org/10.1161/01.CIR.0000158483.13093.9D
Cited by
- Are there any new reliable markers to detect renal injury in obese children? vol.40, pp.1, 2018, https://doi.org/10.1080/0886022X.2018.1489284